Theravance Biopharma Inc. (TBPH) climbed 5.72% or 1.66 to $30.67. It is near to 146449 shares traded, which is 88.79% compare to the average total volume 164935. The market cap of TBPH is $1.69 billion. The year to date change is 9.07%. The 52 week price range is from $21.27 to $35.9. Price of TBPH have changed 7.40% during last week. It have changed 4.69% over last month, 26.19% over last 3 months, 8.94% over last 6 months and -14.20% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 27.25. It is -11.15% below current price. The 200-day Moving Averages for TBPH is 26.15. It is -14.74% below current price. The 52-week High is 35.9. It is 17.05% from the current price. The 52-week Low is 21.27. It is -30.65% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of TBPH is 22.32 on 2018-08-31. Short % to float is 11.65%. There are some statistics of TBPH. It is has market cap $1.69 billion. The share outstanding is 55.10 million. The average volume is 164935. The revenue is 4.28M. The gross profit is 3.29M. The percent of top 15 Institution holding is 78.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is -184.85%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -53.13%.